Quarterly report [Sections 13 or 15(d)]

Segment Information - Schedule of Consolidated Statements of Operations (Details)

v3.25.2
Segment Information - Schedule of Consolidated Statements of Operations (Details) - Other Operating Segment [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Consolidated Statements of Operations [Line Items]        
Salaries and related expenses, other than share-based compensation $ 1,932 $ 3,521 $ 3,909 $ 5,900
Clinical trials 3,424 3,034 7,049 4,720
Stock based compensation 696 77 1,355 254
Depreciation expenses 292 331 528 560
Other segment items [1] 1,089 2,762 2,348 5,076
Total Operating expenses $ 7,433 $ 9,725 $ 15,189 $ 16,510
[1] Other segment items include all remaining costs necessary to operate the Company’s business, which primarily include external professional services, rent, insurance and other administrative expenses, and are presented net of grants received.